Efficacy and safety of camrelizumab combined with apatinib in the treatment of advanced gastric cancer: Preliminary results from a multicenter, prospective study.

被引：0
|
作者：
He, Yifu
Hu, Bing
Liu, Ke
Cheng, Xiaofei
Cheng, Huaidong
Chen, Mo
Hu, Changlu
Li, Chenghui
Mei, Xinkuan
Liu, Jianfeng
Liu, Hu
Wang, Gang
Li, Hongxia
Zhang, Dingqing
Luo, Huiqin
机构：
[1] Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China
[2] Anhui Med Univ, Chaohu Hosp, Hefei, Peoples R China
[3] Peoples Liberat Army Navy Anqing Hosp, Anqing, Peoples R China
[4] Anhui Med Univ, Hosp 2, Hefei, Peoples R China
[5] Anhui 2 Prov Peoples Hosp, Hefei, Peoples R China
[6] Anhui Prov Canc Hosp, Hefei, Peoples R China
[7] Anqing Municipal Hosp, Anqing, Peoples R China
[8] Fuyang Canc Hosp, Fuyang, Peoples R China
[9] Lujiang Cty Hosp Tradit Chinese Med, Hefei, Peoples R China
[10] Hefei First Peoples Hosp, Hefei, Peoples R China
[11] Qianshan Hosp Tradit Chinese Med, Anqing, Peoples R China
[12] USTC West Dist, Affiliated Hosp 1, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16035
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis
    Ma, Yongli
    Li, Jinghui
    Wen, Liang
    Zhang, Guosheng
    Yao, Xueqing
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [42] Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis
    Yongli Ma
    Jinghui Li
    Liang Wen
    Guosheng Zhang
    Xueqing Yao
    World Journal of Surgical Oncology, 21
  • [43] Neoadjuvant nivolumab monotherapy in patients with resectable gastric cancer: Preliminary results from a multicenter study.
    Takiguchi, Shuji
    Shitara, Kohei
    Takiguchi, Noriaki
    Ito, Seiji
    Kochi, Mitsugu
    Horinouchi, Hidehito
    Kinoshita, Takahiro
    Muro, Kei
    Yoshikawa, Takaki
    Hasegawa, Hirotaka
    Nishikawa, Hiroyoshi
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.
    Li, Jin
    Qin, Shukui
    Wen, Lu
    Wang, Junsheng
    Deng, Wenying
    Guo, Weijian
    Jia, Tongfu
    Jiang, Da
    Zhang, Guifang
    He, Yifu
    Zhong, Haijun
    Ba, Yi
    Lin, Xiaoyan
    Yang, Jianwei
    Zhao, Jun
    Bai, Yuxian
    Wu, Xiangyuan
    Gao, Feng
    Sun, Ying
    Hou, Zhiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Safety of apatinib as third-line or beyond treatment in advanced or metastatic gastric cancer: Results from a multicenter phase IV study (Ahead-G201).
    Li, Jin
    Wen, Lu
    Wang, Junsheng
    Deng, Wenying
    Zhang, Guifang
    Jia, Tongfu
    Ba, Yi
    Zhong, Haijun
    Yang, Jianwei
    Lin, Xiaoyan
    Bai, Yu-Xian
    He, Yifu
    Xie, Zhong
    Yi, Tienan
    Wu, Xiangyuan
    Ye, Feng
    Liu, Likun
    Huang, Yong
    Wang, Mei
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective clinical study (data updated)
    Yang, M.
    Gao, J.
    Liu, X.
    Xu, Z.
    Lu, H.
    Yang, W.
    Li, H.
    Li, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective clinical study (data updated)
    Yang, M.
    Gao, J.
    Liu, X.
    Lu, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S903 - S903
  • [48] Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective randomized controlled clinical study
    Wang, Z.
    Dai, G.
    Zhou, Y.
    Hui, H.
    Zhang, P.
    Gou, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Camrelizumab combined with SOX regimen in the first-line treatment of unresectable advanced or recurrent gastric cancer: A single-arm, prospective, open clinical study.
    Han, Zhengxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
    Liu, Jieqiong
    Liu, Qiang
    Li, Ying
    Li, Qian
    Su, Fengxi
    Yao, Herui
    Su, Shicheng
    Wang, Quanren
    Jin, Liang
    Wang, Ying
    Lau, Wan Yee
    Jiang, Zefei
    Song, Erwei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345